MetaStat Inc MTST
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.08
- Market Cap
- $587.74
- Volume/Avg
- 100 / 100
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MetaStat Inc is a US-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 6
- Website
- http://www.metastat.com
Valuation
Metric
|
MTST
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
MTST
Financial Strength
Metric
|
MTST
|
---|---|
Quick Ratio | 0.15 |
Current Ratio | 0.16 |
Interest Coverage | −25.67 |
Quick Ratio
MTST
Profitability
Metric
|
MTST
|
---|---|
Return on Assets (Normalized) | −245.94% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MTST
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Dltgnmfwlr | Kqkwh | $570.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cwkqgnx | Yjpgqzn | $108.0 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Vlpzzjr | Pwhmpg | $105.6 Bil | |
MRNA
| Moderna Inc | Nsmmgfnq | Cvk | $40.8 Bil | |
ARGX
| argenx SE ADR | Mxvhvwkm | Lksp | $23.5 Bil | |
BNTX
| BioNTech SE ADR | Sthyjznc | Qprrj | $21.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Bjhxvvcbs | Lsrcs | $18.8 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rcvrdbhh | Nwbvm | $16.5 Bil | |
RPRX
| Royalty Pharma PLC Class A | Jxqtlycrd | Kjjbbh | $13.6 Bil | |
INCY
| Incyte Corp | Qpbgnsvb | Mwnxhp | $12.8 Bil |